Introduction Accurate early diagnosis of Parkinson\u27s disease is hampered by its long prodromal period and the variable manifestations of its motor symptoms. While olfactory dysfunction can occur before motor-symptom onset and serve as a non-disease-specific diagnostic aid, its underlying causes are incompletely understood. Methods Correlation analyses, univariate density estimates, ANOVA and regression evaluated relationships between scores on the Montreal Cognitive Assessment and Hopkins Verbal Learning Test and those on the University of Pennsylvania Smell Identification Test in 1280 Parkinson\u27s Progression Markers Initiative subjects placed into five diagnostic categories. Structural equation modeling identified cognitive measures ...
Background: Olfactory dysfunction in Parkinson\u27s disease (PD) is well-established and may represe...
Mild cognitive impairment (MCI) and olfactory dysfunction are non-motor symptoms of Parkinson’s dise...
Objectives: olfactory dysfunctions increase with age, 2% of the population under 65 years and 75% ov...
Introduction. Olfactory and cognitive disorders represent important non-motor symptoms in Parkinson’...
Parkinson’s disease (PD) is a progressive, incurable neurodegenerative disease thatcauses slowness, ...
Objective: To investigate whether baseline olfactory dysfunction in Parkinson's disease (PD) patient...
Background: Olfactory deficits and executive dysfunction have been reported in Parkinson's disease (...
Olfactory decline is a frequent and early non-motor symptom in Parkinson’s disease (PD), which is in...
INTRODUCTION: Although white matter hyperintensities (WMH) and olfactory dysfunction are independent...
Olfactory deficit is a widely documented non-motor symptom in Parkinson's disease (PD). Abnormal tur...
Olfactory dysfunction is associated with normal aging, multiple neurodegenerative disorders, includi...
OBJECTIVE: To explore whether olfactory performance acts as a cognitive reserve in non-demented pati...
Although Parkinson’s disease (PD) is usually considered as a movement disorder, it is strongly assoc...
Abstract Objectives: Although Parkinson's disease (PD) is usually described as a movement disorder,...
Background. Loss of olfaction is a well-established early feature of Parkinson’s disease (PD). Altho...
Background: Olfactory dysfunction in Parkinson\u27s disease (PD) is well-established and may represe...
Mild cognitive impairment (MCI) and olfactory dysfunction are non-motor symptoms of Parkinson’s dise...
Objectives: olfactory dysfunctions increase with age, 2% of the population under 65 years and 75% ov...
Introduction. Olfactory and cognitive disorders represent important non-motor symptoms in Parkinson’...
Parkinson’s disease (PD) is a progressive, incurable neurodegenerative disease thatcauses slowness, ...
Objective: To investigate whether baseline olfactory dysfunction in Parkinson's disease (PD) patient...
Background: Olfactory deficits and executive dysfunction have been reported in Parkinson's disease (...
Olfactory decline is a frequent and early non-motor symptom in Parkinson’s disease (PD), which is in...
INTRODUCTION: Although white matter hyperintensities (WMH) and olfactory dysfunction are independent...
Olfactory deficit is a widely documented non-motor symptom in Parkinson's disease (PD). Abnormal tur...
Olfactory dysfunction is associated with normal aging, multiple neurodegenerative disorders, includi...
OBJECTIVE: To explore whether olfactory performance acts as a cognitive reserve in non-demented pati...
Although Parkinson’s disease (PD) is usually considered as a movement disorder, it is strongly assoc...
Abstract Objectives: Although Parkinson's disease (PD) is usually described as a movement disorder,...
Background. Loss of olfaction is a well-established early feature of Parkinson’s disease (PD). Altho...
Background: Olfactory dysfunction in Parkinson\u27s disease (PD) is well-established and may represe...
Mild cognitive impairment (MCI) and olfactory dysfunction are non-motor symptoms of Parkinson’s dise...
Objectives: olfactory dysfunctions increase with age, 2% of the population under 65 years and 75% ov...